Maintaining Integrity of the Supply Chain

Jul 1, 2014

For the pharmaceutical industry, the prevalence of counterfeit drugs can represent loss of reputation, loss of valuable R&D efforts and intellectual property, loss of revenue, and increased costs. Sue Lee of World Courier asks what can pharmaceutical professionals do to ensure that their organisations and the patients they serve are not impacted by counterfeit drugs? The answer is to identify their highest risk products and shipments and to secure their supply chain to the fullest extent possible. ...

Read More

Aseptic Pharmaceutical Processing: It All Begins in The Lab

Jul 1, 2014

The drive towards novel drug presentation and injectable-grade products is generating increased demand for aseptic pharmaceutical processing, including aseptic spray-drying (ASD). But what considerations need to be made for aseptic spray-drying programmes at laboratory stage to enable them to be efficiently scaled up from feasibility assessment to large-scale manufacture? Sam de Costa of Nova Laboratories shares his insights and considerations for a smooth transition. ...

Read More